Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Medtronic and Arbor Surgical Technologies have announced an exclusive global licensing agreement under which Medtronic will manufacture, market and distribute Arbor's bovine pericardial tissue heart valve technologies.
Subscribe to our email newsletter
In addition, Medtronic has acquired a minority stake in Arbor. Arbor retains its exclusive rights to the modular Trilogy Aortic Valve System and sutureless TRE implantation technologies. The technology will complement Medtronic’s Structural Heart Disease therapy objectives, which are focused on developing effective options for valve disease, septal defects and atrial fibrillation.
John Liddicoat, vice president and general manager of the structural heart disease business at Medtronic, said: “We are optimistic that Arbor’s pericardial valve design combined with Medtronic’s proprietary technologies will achieve best-in-class performance.”